Danaher (DHR) Jumps on Improved Q3 Earnings

We recently published 10 Stocks Leaving Wall Street in the Dust. Danaher Corp. (NYSE:DHR) is one of the best performers on Tuesday.

Danaher bounced back by 5.94 percent on Tuesday to close at $220.77 apiece after achieving an improved earnings performance in the third quarter of the year.

In an updated report, Danaher Corp. (NYSE:DHR) said net income jumped by 11 percent to $908 million from $818 million in the same period last year. Sales grew by 4.4 percent to $6.05 billion from $5.798 billion year-on-year.

For the nine-month period, net income declined by 14 percent to $2.417 billion from $2.813 billion in the same comparable period, while sales inched up by 2.27 percent to $17.73 billion from $17.3 billion year-on-year.

Danaher Corp. (NYSE:DHR) President and CEO Rainer Blair said he was encouraged by the results, driven by Danaher Business System-driven execution coupled with continued momentum in the bioprocessing business and better-than-anticipated respiratory revenue at Cepheid.

“We’re investing in breakthrough innovation, enhancing our commercial execution, and driving meaningful productivity gains across our businesses. We believe these efforts will strengthen our long-term competitive position and help to solve some of the world’s most difficult healthcare challenges,” he added.

For the full-year 2025, Danaher Corp. (NYSE:DHR) reaffirmed its guidance of $7.70 to $7.80 for adjusted diluted net earnings per common share. This assumes that non-GAAP core revenue will grow by low single digits year-on-year.

While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.